Dis-Chem Pharmacies (JSE:DCP) Piotroski F-Score: 5 (As of Jun. 27, 2026) — Near Median


JSE:DCP Dis-Chem Pharmacies Ltd JSE:DCP
88 GF Score
Price R33.49
GF Value R38.03
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Dis-Chem Pharmacies Piotroski F-Score?

Dis-Chem Pharmacies JSE:DCP +1.82% 88 Piotroski F-Score is 5 as of Jun. 27, 2026, which is at its 10-year median of 5.00. GuruFocus rates JSE:DCP with a GF Score™ of 88/100 and a GF Value™ of R38.03 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 652 Healthcare Providers & Services companies, Dis-Chem Pharmacies ranks better than 54.6% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Dis-Chem Pharmacies has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Dis-Chem Pharmacies's Piotroski F-Score or its related term are showing as below:

JSE:DCP' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 5   Max: 7
Current: 5

During the past 13 years, the highest Piotroski F-Score of Dis-Chem Pharmacies was 7. The lowest was 3. And the median was 5.

Dis-Chem Pharmacies  (JSE:DCP) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Dis-Chem Pharmacies Piotroski F-Score Related Terms


Dis-Chem Pharmacies Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Dis-Chem Pharmacies's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dis-Chem Pharmacies Piotroski F-Score Chart

Dis-Chem Pharmacies Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.00 7.00 6.00 5.00 5.00

Dis-Chem Pharmacies Semi-Annual Data
Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 0.00 5.00 0.00 5.00

Dis-Chem Pharmacies Piotroski F-Score Competitor Comparison

For the Pharmaceutical Retailers subindustry, Dis-Chem Pharmacies's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dis-Chem Pharmacies Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dis-Chem Pharmacies's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Dis-Chem Pharmacies's Piotroski F-Score falls into.


JSE:DCP
88GF Score
Dis-Chem Pharmacies Ltd JSE:DCP
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Feb26) TTM:Last Year (Feb25) TTM:
Net Income was R979 Mil.
Cash Flow from Operations was R1,793 Mil.
Revenue was R42,826 Mil.
Gross Profit was R9,409 Mil.
Average Total Assets from the begining of this year (Feb25)
to the end of this year (Feb26) was (19256.941 + 20738.283) / 2 = R19997.612 Mil.
Total Assets at the begining of this year (Feb25) was R19,257 Mil.
Long-Term Debt & Capital Lease Obligation was R3,758 Mil.
Total Current Assets was R12,341 Mil.
Total Current Liabilities was R11,163 Mil.
Net Income was R1,180 Mil.

Revenue was R39,172 Mil.
Gross Profit was R8,800 Mil.
Average Total Assets from the begining of last year (Feb24)
to the end of last year (Feb25) was (17500.986 + 19256.941) / 2 = R18378.9635 Mil.
Total Assets at the begining of last year (Feb24) was R17,501 Mil.
Long-Term Debt & Capital Lease Obligation was R3,725 Mil.
Total Current Assets was R11,945 Mil.
Total Current Liabilities was R10,178 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Dis-Chem Pharmacies's current Net Income (TTM) was 979. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Dis-Chem Pharmacies's current Cash Flow from Operations (TTM) was 1,793. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Feb25)
=978.894/19256.941
=0.05083331

ROA (Last Year)=Net Income/Total Assets (Feb24)
=1179.809/17500.986
=0.06741386

Dis-Chem Pharmacies's return on assets of this year was 0.05083331. Dis-Chem Pharmacies's return on assets of last year was 0.06741386. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Dis-Chem Pharmacies's current Net Income (TTM) was 979. Dis-Chem Pharmacies's current Cash Flow from Operations (TTM) was 1,793. ==> 1,793 > 979 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Feb26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Feb25 to Feb26
=3757.966/19997.612
=0.18792074

Gearing (Last Year: Feb25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Feb24 to Feb25
=3724.733/18378.9635
=0.20266284

Dis-Chem Pharmacies's gearing of this year was 0.18792074. Dis-Chem Pharmacies's gearing of last year was 0.20266284. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Feb26)=Total Current Assets/Total Current Liabilities
=12341.477/11163.051
=1.10556487

Current Ratio (Last Year: Feb25)=Total Current Assets/Total Current Liabilities
=11944.913/10177.823
=1.17362161

Dis-Chem Pharmacies's current ratio of this year was 1.10556487. Dis-Chem Pharmacies's current ratio of last year was 1.17362161. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Dis-Chem Pharmacies's number of shares in issue this year was 857.818. Dis-Chem Pharmacies's number of shares in issue last year was 858.056. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=9409.179/42825.777
=0.21970831

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=8800.375/39172.347
=0.22465784

Dis-Chem Pharmacies's gross margin of this year was 0.21970831. Dis-Chem Pharmacies's gross margin of last year was 0.22465784. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Feb25)
=42825.777/19256.941
=2.22391381

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Feb24)
=39172.347/17500.986
=2.23829372

Dis-Chem Pharmacies's asset turnover of this year was 2.22391381. Dis-Chem Pharmacies's asset turnover of last year was 2.23829372. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+0+1+0+0
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Dis-Chem Pharmacies has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
Dis-Chem Pharmacies (JSE:DCP) has a Piotroski F-Score of 5 as of Jun. 27, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Dis-Chem Pharmacies and its competitors. This is near median its historical median of 5.00. Over the past decade, Dis-Chem Pharmacies' Piotroski F-Score has ranged from 3.00 to 7.00. According to the industry distribution chart, Dis-Chem Pharmacies ranks #296 out of 652 companies in the Healthcare Providers & Services industry, placing it in the top 45.4%.
Is Dis-Chem Pharmacies' Piotroski F-Score too high?
Dis-Chem Pharmacies' current Piotroski F-Score of 5 is near median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 7.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Dis-Chem Pharmacies' value of 5 is 0% at this industry median. Based on the distribution chart, Dis-Chem Pharmacies ranks #296 out of 652 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Dis-Chem Pharmacies has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dis-Chem Pharmacies' Piotroski F-Score compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Dis-Chem Pharmacies ranks #296 out of 652 companies for Piotroski F-Score. This puts Dis-Chem Pharmacies in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Dis-Chem Pharmacies' value of 5 is 0% at this benchmark. Historically, Dis-Chem Pharmacies' own Piotroski F-Score has ranged from 3.00 to 7.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Dis-Chem Pharmacies has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 652 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dis-Chem Pharmacies's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Dis-Chem Pharmacies and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dis-Chem Pharmacies's current Piotroski F-Score is 5, which is near median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dis-Chem Pharmacies stock overvalued right now?
Based on GuruFocus' analysis, Dis-Chem Pharmacies (JSE:DCP) is currently considered Modestly Undervalued. The stock's GF Value™ is R38.03, compared to a current price of R33.49 — trading 11.9% below its estimated fair value. The current Piotroski F-Score is 5, which is near median its 10-year median of 5.00 and 0% at the Healthcare Providers & Services industry median of 5.00. Dis-Chem Pharmacies' overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Dis-Chem Pharmacies (JSE:DCP), the current Piotroski F-Score is 5 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dis-Chem Pharmacies (JSE:DCP) Overvalued in 2026?

Based on GuruFocus' analysis, Dis-Chem Pharmacies stock appears to be undervalued. The current stock price of R33.49 is trading 11.9% below its estimated GF Value™ of R38.03. GuruFocus considers Dis-Chem Pharmacies to be Modestly Undervalued.

Key valuation signals for JSE:DCP:

  • Piotroski F-Score: 5 (near median its 10-year median of 5.00)
  • GF Value™: R38.03 vs. price of R33.49 (11.9% below fair value)
  • GF Score™: 88/100 with 5 warning signs
  • Industry Position: 0% at the Healthcare Providers & Services median (#296 of 652)

No single metric tells the full story. See the JSE:DCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dis-Chem Pharmacies Business Description

Address 23 Stag Road, Glen Austin, Midrand, Johannesburg, GT, ZAF, 1685
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceuticals and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries out its business operations principally in South Africa.
88GF Score

Get the complete analysis for JSE:DCP

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R33.49
Price
R38.03
GF Value